HRT
The Royal College of Obstetricians and Gynaecologists (RCOG) call for action over shortages of hormone replacement therapy (HRT)
August 27, 2019Manufacturing and Production HRT, UK, healthcare, pharma, shortages
The Royal College of Obstetricians and Gynaecologists (RCOG) have called for action from government and pharmaceutical companies to adress ongoing …
HRT pills linked to increase in clots and strokes
March 10, 2015Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy
HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …
Hormone replacement therapy elevates ovarian cancer risk
February 13, 2015Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian
According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer. Findings …
Evidence HRT could reduce bowel cancer risk
February 2, 2009Research and Development, Sales and Marketing HRT
A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …
Latest news from Datamonitor
November 10, 2008Research and Development, Sales and Marketing HRT
Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …
HRT – Too great a risk ?
November 4, 2003Research and Development HRT, clinical trial
The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …
Latest content
FibroFind appoints Lee Borthwick as CEO
